References
- Agyeman AS , BandukwalaA, BouriKet al. US FDA public meeting: identification of concepts and terminology for multicomponent biomarkers. Biomark. Med.17(11), 523–531 (2023).
- Genç Ö , YildirimA, GençMet al. Comparison of thromboembolic risk scores for evaluating in-hospital events of COVID-19 patients. Biomark. Med.17(2), 59–72 (2023).
- Yang N , GaoJ, HanYet al. Serum CDC42 reflects the exacerbation risk and severity, Th1/2 cell imbalance and inflammation in asthmatic children. Biomark. Med. Vol.17(8), 407–415 (2023).
- Zheng Z , WangP. Serum ATG5 concentration relates to Th2 cell, nasal symptoms and therapeutic outcomes in allergic rhinitis patients. Biomark. Med.17(8), 437–444 (2023).
- Zhang Z , WangH, JinYet al. KRT15 in early breast cancer screening and correlation with HER2 positivity, pathological grade and N stage. Biomark. Med.17(12), 553–562 (2023).
- Erdogan A , GencO, InanDet al. Impact of Naples Prognostic Score on midterm all-cause mortality in patients with decompensated heart failure. Biomark. Med.17(4), 219–223 (2023).
- Fan Y , YeZ, TangY. Serum HMGB1 and soluble urokinase plasminogen activator receptor levels aid diagnosis and prognosis prediction of sepsis with acute respiratory distress syndrome. Biomark. Med.17(4), 231–239 (2023).
- Farouk S , El-ShenawyR, KhairyAMet al. Overexpression of miRNA 26a and 26b with MMP-9 are valuable diagnostic biomarkers for colorectal cancer patients. Biomark. Med.17(3), 159–169 (2023).
- Tashakori M , JamalizadehA, Nejad-GhaderiMet al. Association between the copper/selenium ratio and the immune response to SARS-CoV-2 infection. Biomark. Med.17(6), 307–317 (2023).
- Zhang C , YangZ, LuoPet al. Association of TLR4 and TLR9 gene polymorphisms with the risk and progression of cervical lesions in HPV-infected women. Biomark. Med.17(3), 133–142 (2023).
- Kus F , GuvenDC, YildirimHCet al. KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer. Biomark. Med.17(7), 379–389 (2023).
- Nübel J , HoffmeisterM, LabrenzOet al. NT-proBNP/urine hepcidin-25 ratio and cardiorenal syndrome type 1 in patients with severe symptomatic aortic stenosis. Biomark. Med. Vol.17(10), 475–485 (2023).
- Gacci M , NunzioCD, GravasS. Unveiling prostatic inflammation to optimize management of lower urinary tract symptoms: a discussion with experts. Biomark. Med.17(18), 739–745 (2023).
- Kaygusuz TÖ , TartarAS, BalinŞÖet al. Predictive epidemiological, clinical and laboratory parameters in the diagnosis of Crimean–Congo hemorrhagic fever. Biomark. Med.17(11), 533–540 (2023).
- Zhang Q , MaoW, HeXet al. High red cell distribution width-to-platelet ratio indicates adverse outcomes for hepatitis B virus-associated decompensated cirrhosis. Biomark. Med.17(4), 189–196 (2023).